Mostrar el registro sencillo

dc.contributor.authorHeras-Recuero, Elena
dc.contributor.authorBlázquez-Sánchez, Teresa
dc.contributor.authorLandaeta-Kancev, Laura Cristina
dc.contributor.authorMartínez de Bourio-Allona, Marta
dc.contributor.authorTorres-Roselló, Arantxa
dc.contributor.authorRengifo-García, Fernando
dc.contributor.authorCaraballo-Salazar, Claritza
dc.contributor.authorLago, Raquel
dc.contributor.authorCastañeda, Santos
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2024-11-07T17:30:36Z
dc.date.available2024-11-07T17:30:36Z
dc.date.issued2024
dc.identifier.issn2075-4418
dc.identifier.urihttps://hdl.handle.net/10902/34436
dc.description.abstractPolymyalgia rheumatica (PMR) is an inflammatory disease common in people aged 50 years and older. This condition is characterized by the presence of pain and stiffness involving mainly the shoulder and pelvic girdle. Besides the frequent association with giant cell arteritis (GCA), several conditions may mimic PMR or present with PMR features. Since the diagnosis is basically clinical, an adequate diagnosis of this condition is usually required. Positron emission tomography/computed tomography (PET-CT) has proved to be a useful tool for the diagnosis of PMR. The use of 18F-FDG-PET imaging appears promising as it provides detailed information on inflammatory activity that may not be evident with traditional methods. However, since PET-CT is not strictly necessary for the diagnosis of PMR, clinicians should consider several situations in which this imaging technique can be used in patients with suspected PMR.es_ES
dc.description.sponsorshipFunding: Miguel Ángel González-Gay research was supported by the Spanish Red de Investigación RICORS RD21/0002/0025 of the Instituto de Salud Carlos III, Spain.es_ES
dc.format.extent15 p.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rights© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceDiagnostics, 2024, 14, 1539es_ES
dc.subject.otherFDG uptakees_ES
dc.subject.otherPolymyalgia rheumaticaes_ES
dc.subject.otherGiant cell arteritises_ES
dc.subject.otherPositron emission tomography/computed tomography (PET-CT) with 18F-fluorodeoxyglucose (FDG)es_ES
dc.titlePositron emission tomography/computed tomography in polymyalgia rheumatica: when and for what: a critical reviewes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3390/diagnostics14141539es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3390/diagnostics14141539
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.Excepto si se señala otra cosa, la licencia del ítem se describe como © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.